| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |